migration (metastasis) [Figures 1 and 2] . Oncomodulatory viruses, such as human cytomegaloviruses (HCMV), are known to release over 200 proteins, many of which can alter tumor behavior [ Table 1 ].
In the past, the debate was centered on the idea that for a virus to have oncogenic effects, all of the cells in the tumor must be infected. Until recently, most studies used inadequate technology to detect these viruses. Most importantly, it was determined that it was not necessary for all of the tumor cells to be infected with the virus in question. Rather, only a few cells need to be infected, with the release of viral proteins from the viruses, which occupy most if not all of the tumor cells, including stromal cells. is finding invalidates many of the previously reported negative studies.
CHRONIC INFLAMMATION, VIRUSES, AND THE DEVELOPMENT OF CANCER CELLS
Some concluded that the virus was present in the tumor merely because the tumor supplied a growth environment that was favorable to the virus. Newer studies have elucidated a number of mechanisms, by which these viruses affect tumor biology and aggressiveness.
It is now accepted that inflammation is playing a central role in most, if not all, cancers [ Figure 2 ]. Inflammation is known to activate HCMV and the virus, in turn, activates intense inflammation as well, which maintains tumor progression into an aggressive behavior. Inflammation is known to be operational throughout all stages of the cancer process.
Tumors are composed of not only cancer cells but also over 50% stromal cells, which make up the tumor's microenvironment. Within this microenvironment, one sees a number of cell types, including T-cells, B-cells, NK cells, fibroblast, adipocytes, vascular endothelial cells, and pericytes, all of which crosstalk and release factors that support tumor survival, growth, invasion, and migration.
VIRUSES INFECTING IMMUNE CELLS AND TUMOR CELLS: CHANGING IMMUNE CELLS TO BECOME IMMUNOSUPPRESSIVE AND PRODUCE FACTORS CHANGING TUMOR CELL METABOLISM
HCMV preferentially infects immune cells and tumor stem cells. e infected immune cells assume an immunosuppressive phenotype and there is evidence that HCMV-infected cells can produce a protein that resembles IL-10 (cmvIL-10), a major immune suppressing protein [ Figure 3 ]. e cell survival protein TGF-ß is also activated by the HCMV virus.
A number of immune cytokines play critical roles in cancer behavior, including tumour necrosis factor-α and IL-6, HCMV also stimulates the PI3K/AKt cell-signaling pathway, which enhances cell proliferation and promotes cell survival by reducing apoptotic proteins, such as BAD, and activating cell survival proteins, such as bcl-2 and bcl-XL [ Figure 5 ].
Tumor microenvironment hypoxia is known to make cancer significantly more aggressive, mainly by activating hypoxiainducible factor-1α. is factor is also a major inducer of angiogenesis. Oncomodulatory viral proteins are also known to potently stimulate the production of angiogenic factors. HCMV is unique in promoting the release of a powerful secretome from cells in the tumor microenvironment, which contains the tumor invasion factor matrix metalloproteinase and the growth factors such as vascular endothelial growth factor, basic fibroblast growth factor (FGF), FGF-binding protein, and platelet-derived growth factor. In addition, HCMV enhances the formation of telomerase (human telomerase reverse transcriptase), which promotes tumor cell survival. 
AcƟvaƟon of telomeres
which are both linked to activation of the transcription factor, NFκB. is transcription factor is intensely activated in most cancers. IL-6 generation by NFκB plays a major role in tumor aggressiveness, and cancers with high levels of this cytokine have a poor prognosis. HCMV activates all of these factors [ Figure 3 ]. Interestingly, chemotherapy and radiotherapy can activate HCMV, thus affecting cancer prognosis, should there be a relapse or treatment failurewhich would have the potential of making the tumor even more aggressive.
VIRUSES INFLUENCING TUMOR CELL SIGNALING PATHWAYS LEADING TO TUMOR CELL GROWTH
Another way oncomodulatory viruses influence tumor biology is by affecting cell signaling. HCMV and other oncomodulatory viruses have been shown to activate the JAK/Stat pathway toward overproduction of STAT3, which has a number of effects supporting tumor aggressiveness, including stimulating intense inflammation, suppression of antitumor immunity, stimulation of cancer cell proliferation, inhibiting apoptosis mechanisms, stimulating survival
VIRUSES ALTERING THE TUMOR CELL METABOLISM
Finally, oncomodulatory viruses also affect the metabolism of cancer cells [ Figure 6 ]. On conversion to cancer cells, we see an alteration in the cell's metabolism, in which glucose transfer into the cancer cells is remarkably enhanced, along with a conversion in metabolism that favors aerobic glycolysis (an in some instances anaerobic glycolysis) and an alteration in Kreb's cycle (TCA cycle) that enhances the use of intermediates for biosynthesis of molecules used by the tumor cells and viruses for construction of vital elements such as nucleotides, lipids, and amino acids [ Figure 7 ]. ese factors are also used to generate new cancer cells. Oxidative phosphorylation is inhibited, thus reducing the energy efficiency of the cancer cell. is has been named the Warburg effect [ Figure 8 ]. 
GLUTAMINE STIMULATES TUMOR CELL GROWTH
Glioblastomas are known to have high levels of glutamine consumption and are glutamine addicted. e oncogene, c-myc, plays a major role in converting cancer cells to glutamate/glutamine dependence. Tumors with the highest c-myc levels also have the highest glutamate levels.
Interestingly, glutaminolysis is not the major source of glutamate in tumors. Recent studies have shown that most of the extracellular glutamate within the tumor microenvironment comes from the cystine/glutamate Xc antiporter, a membrane exchange system that exchanges extracellular cystine for intracellular glutamate. Once inside the cell, the cystine is metabolized to form glutathione, which protects the cell. e extruded glutamate raises the extracellular glutamate levels, which could trigger a cascade of neurodestruction. is is normally prevented by the presence of glutamate transport proteins that move the extracellular glutamate inside astrocytes and microglia, where it is safe. e most abundant of these transfer proteins is GLT-1 (EAAT2), which is absent in gliomas, thus allowing glutamate to rise to excitotoxic levels in the extracellular space.
While glutamate stimulates tumor growth by glutaminolysis, it also does so by the stimulation of glutamate receptors [ Tables 2 and 3 ]. Brain tumors with high levels of extracellular glutamate are more aggressive, more invasive and have a much shorter survival period. Extensive studies have found that blocking particular glutamate receptors can suppress tumor growth and invasion.
TUMOR CELL MIGRATION EFFECTED BY GLUTAMATE ACTIVATED GLUTAMATE RECEPTORS ON THE TUMOR CELL
Tumor cells migrate much in the same way as embryonic cells, which are driven by gradients of glutamate. Studies have shown that migration of both types of cells, embryonic and cancer cells, is dependent on calcium oscillation (varying gradients of calcium), which are determined by calcium-controlling glutamate receptors [ Figure 8 ]. Normally, one would suspect the NMDA receptor to be most involved, but in most cancers, this receptor is inactive.
Under most normal conditions, the AMPA-type glutamate receptors are calcium impermeable, meaning they do not regulate calcium entry into the cell. Under inflammatory conditions, as with cancers, special calcium-permeable AMPA receptors are recruited to the synaptic plate [ Figure 7 ]. Like the functional NMDA receptors, these special receptors, when activated, allow large concentrations of calcium to enter the cell. HCMV viruses can also convert AMPA receptors into calcium-permeable receptors. is stimulates cancer cell proliferation, invasion, and migration (metastasis).
TREATMENT OF VIRUSES BY ANTIVIRAL MEDICATIONS AND NATURAL COMPOUNDS
As one can see, these oncomodulatory viruses can play a major role in tumor behavior, potentially converting an otherwise curable cancer into an incurable one. A number of studies have shown that treating these viruses with antiviral medications and similar substances can reduce the malignant potential of many types of tumors. It is also encouraging to note that several natural compounds, each with a high margin of safety, can also dramatically reduce viral loads, potentially having the same beneficial effects as the antiviral medications. Most such compounds also have a number of other anticancer effects and are much safer than antiviral medications.
DNA MUTATIONS NOT NECESSARY FOR CANCER CELL DEVELOPMENT: CHRONIC INFLAMMATION AND VIRUSES CAN CAUSE EXCESSIVE STIMULATION OF CELL-SIGNALING PATHWAYS THAT CAN PRODUCE CANCER CELLS
One important observation that has changed our thinking in the field of oncology is that DNA mutations are not 
CONCLUSION
Over the past 30 years, we have learned a great deal about the incredibly complex mechanisms involved in the transformation of normal cells into cancer cells, especially as regards cell-signaling pathways. While mutations and epigenetic overexpression of genes can result in this transformation, increasing evidence suggest that overactivation of critical cell signaling pathways can also result in transformation of cells toward malignancy. Universal to both genetic and cell-signaling induced malignant transformation is the inflammatory process, especially chronic, low-grade inflammation. Inflammation not only increases free radical generation and lipid peroxidation products that can damage and mutate oncogenes but can also directly overactivate cell-signaling pathways essential to carcinogenesis and tumor behavior.
Recent evidence demonstrates a much higher incidence of viral infection of a number of cancerous tumors than previously appreciated, based on greatly improved detection systems and the realization that all tumor cells do not have to be infected to make the link. Recent studies have shown that infection of a small number of cells, especially cancer stem cells and progenitor cells, can result in the release of a large number of viral proteins that can infect numerous tumor and stromal cells in the microenvironment, and as a result, trigger carcinogenesis and of equal importance, can drive a number of tumor mechanisms involved in tumor cell metabolism, immune resistance, proliferation, tumor invasion, and tumor cell migration. Potentially, this can convert relatively benign, mostly localized cancers to become more aggressive, rapidly growing, more invasive, and more likely to metastasize than they would otherwise.
e ability of infectious organisms to alter tumor biology has been termed oncomodulation.
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